Why did TMD.TO stock spike pre-market?

The pre-market spike likely reflects low float and concentrated retail buying. Volume hit **117,220** versus an average of **45,936**, producing sharp intraday moves. No confirmed Titan release was visible at the time.

What is the Meyka AI grade for TMD.TO stock?

Meyka AI rates TMD.TO with a score of **64.67 out of 100**, grade **B**, suggestion **HOLD**. The grade factors in benchmarks, sector and financial metrics and analyst consensus.

What price target does Meyka AI give for TMD.TO stock?

Meyka AI's forecast model projects a 12-month median target of **C$0.85**, implying **-24.44%** from current **C$1.125**. Forecasts are model-based projections and not guarantees.

How risky is trading TMD.TO stock today?

High risk: EPS is **C$-1.73**, the float is thin, and volume spikes can reverse quickly. Use small sizes and strict stops, and wait for confirmed company news for longer-term exposure.

CA Stocks

TMD.TO Titan Medical (TSX) C$1.13 pre-market 02 Feb 2026: 117,220 volume

ByHuzaifa Zahoor February 2, 2026February 2, 2026

TMD.TO stock opened pre-market at C$1.13 on 02 Feb 2026 after a sharp intraday move that pushed volume to 117,220 shares, roughly 2.55x the average. That surge followed a jump from a previous close of C$0.05, a change of 2,150.00%, highlighting an unusually thin float and high volatility in TSX trading. We review drivers, key metrics, and short-term price scenarios for Titan Medical Inc. (TMD.TO) on the TSX in Canada.